Comprehensive mapping of immune perturbations associated with severe COVID-19
Open accessThe DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.
Abstract
Profound plasmablast expansion, innate cell modulation, and T cell activation are defining features of severe COVID-19.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We believe that the features described herein may help to identify the immunopathology of similar illnesses, such as irAEs and CRS due to other immunotherapies (e.g. checkpoint inhibitors, CAR-T-cells) or COVID-19 [4, 18, 19], and to inform discussions on the type and length of clinical and immune monitoring warranted in such patients.”
From Immune reconstitution and clinical recovery following anti-CD28 antibody (TGN1412)-induced cytokine storm (2021) · cites this paper as [19]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Clinical–pathologic correlation in these individuals resulted in valuable observations that may be instructive in understanding mechanisms of immune-induced pathologies, including those of checkpoint inhibitors, CAR-T cells, and infections such as COVID-19, known to target mucosal tissues and cause severe CRS [1, 5, 8, 18, 19].”
From Immune reconstitution and clinical recovery following anti-CD28 antibody (TGN1412)-induced cytokine storm (2021) · cites this paper as [19]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“suggesting the lung as a source for the elevated plasma levels of type I IFNs early on infection”
From COVID-19 and the human innate immune system (2021) · cites this paper as Kuri-Cervantes et al., 2020
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Ineffective IFN innate immunity has been strongly associated with failure to control a primary SARS-CoV-2 infection and a high risk of fatal COVID-19, accompanied by innate cell immunopathology and a plasma cytokine signature of elevated CXCL10, interleukin (IL)-6, and IL-8 in many studies (Aid et al., 2020; Kuri-Cervantes et al., 2020; Li et al., 2020b; Lucas et al., 2020; Radermecker et al., 202”
From Adaptive immunity to SARS-CoV-2 and COVID-19 (2021) · cites this paper as Kuri-Cervantes et al., 2020
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“particularly observation of elevated frequencies of neutrophils (the most common cell type of the innate immune system) in blood (Kuri-Cervantes et al., 2020), and massive numbers of neutrophils in lungs, associated with severe, end-stage COVID-19 disease (Li et al., 2020b; Liao et al., 2020; Radermecker et al., 2020; Schurink et al., 2020). In contrast, end-stage disease is not generally”
From Adaptive immunity to SARS-CoV-2 and COVID-19 (2021) · cites this paper as Kuri-Cervantes et al., 2020
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Wang, X., Xu, W., Hu, G., Xia, S., Sun, Z., Liu, Z., Xie, Y., Zhang, R., Jiang, S., & Lu, L. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0498-4 · Cited by 175
RetractedWang, X., Xu, W., Hu, G., Xia, S., Sun, Z., Liu, Z., Xie, Y., Zhang, R., Jiang, S., & Lu, L. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0424-9 · Cited by 161
RetractedClinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Martínez–González, M. B. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,296
Binary Codes capable of currecting deletions, insertions, and reversals
Levenshtein, V. I. (1965) · Soviet physics. Doklady · Cited by 14,807
Chen, Y., Wang, L., Kang, Q., Zhang, X., Yu, G., Wan, X., Wang, J., & Zhu, K. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000477308 · Cited by 10,679
Research works printed but not linked: 2
- WHO Novel Coronavirus 2019 Reports (World Health Organization 2020) vol. 2020.
- 10.1146/annurev.iy.13.040195.001015 · doi:10.1146/annurev.iy.13.040195.001015 · Paper page
Cited by
Items 301–400 of 761
Immune profiling of COVID-19: preliminary findings and implications for the pandemic
Maecker, H. T. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002550 · Cited by 26
Ligotti, M. E., Pojero, F., Accardi, G., Aiello, A., Caruso, C., Duro, G., & Candore, G. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.725606 · Cited by 26
Neutrophil subsets and their differential roles in viral respiratory diseases
Zhang, Y., Wang, Q., Mackay, C. R., Ng, L. G., & Kwok, I. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.1mr1221-345r · Cited by 28
Niedźwiedzka‐Rystwej, P., Majchrzak, A., Aksak‐Wąs, B., Serwin, K., Czajkowski, Z., Grywalska, E., Korona‐Głowniak, I., Roliński, J., & Parczewski, M. (2022) · Cells · doi:10.3390/cells11121978 · Cited by 26
Biological functions of MAIT cells in tissues
Klenerman, P., Hinks, T., & Ussher, J. E. (2020) · Molecular Immunology · doi:10.1016/j.molimm.2020.12.017 · Cited by 26
Agarwal, R., Chang, J., Côrtes, F. H., Ha, C., Villalpando, J., Castillo, I. N., Gálvez, R. I., Grifoni, A., Sette, A., Romero-Vivas, C. M., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102134 · Cited by 30
COVID-19 and myeloid cells: complex interplay correlates with lung severity
D’Alessio, F. R., & Heller, N. M. (2020) · Journal of Clinical Investigation · doi:10.1172/jci143361 · Cited by 25
Noh, J. Y., Kwak, J.-E., Yang, J., Hwang, S. Y., Yoon, J. G., Seong, H., Hyun, H., Lim, C. S., Yoon, S., Ryou, J., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab124 · Cited by 25
Infection and Immune Memory: Variables in Robust Protection by Vaccines Against SARS-CoV-2
Ahluwalia, P. K., Vaibhav, K., Ahluwalia, M., Mondal, A. K., Sahajpal, N., Rojiani, A. M., & Kolhe, R. B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.660019 · Cited by 29
Molecular and Clinical Prognostic Biomarkers of COVID-19 Severity and Persistence
Papadopoulou, G., Manoloudi, E., Repousi, N., Skoura, L., Hurst, T. P., & Karamitros, T. (2022) · Pathogens · doi:10.3390/pathogens11030311 · Cited by 27
Correlation between Type I Interferon Associated Factors and COVID-19 Severity
Bencze, D., Fekete, T., & Pázmándi, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810968 · Cited by 25
STAT3 signaling in B cells controls germinal center zone organization and recycling
Fike, A. J., Chodisetti, S. B., Wright, N., Bricker, K. N., Domeier, P. P., Maienschein‐Cline, M., Rosenfeld, A. M., Luckenbill, S. A., Weber, J. L., Choi, N. M., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112512 · Cited by 30
Self-citationMertz, P., Jeannel, J., Guffroy, A., Lescuyer, S., Korganow, A., Rondeau-Lutz, M., & Weber, J. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102824 · Cited by 25
A single transcript for the prognosis of disease severity in COVID-19 patients
Lei, H. (2021) · Scientific Reports · doi:10.1038/s41598-021-91754-7 · Cited by 27
Immunosuppression as a Hallmark of Critical COVID-19: Prospective Study
Kalicińska, E., Szymczak, D., Zińczuk, A., Adamik, B., Śmiechowicz, J., Skalec, T., Nowicka‐Suszko, D., Biernat, M., Bogucka‐Fedorczuk, A., Rybka, J., et al. (2021) · Cells · doi:10.3390/cells10061293 · Cited by 26
COVID-19 Vaccines: Current Conditions and Future Prospects
Zieneldien, T., Kim, J., Cao, J. A., & Cao, C. (2021) · Biology · doi:10.3390/biology10100960 · Cited by 25
Self-citationYu, S., Di, C., Chen, S., Guo, M., Yan, J., Zhu, Z., Liu, L., Feng, R., Xie, Y., Zhang, R., et al. (2021) · Cell Research · doi:10.1038/s41422-021-00562-1 · Cited by 28
Differential Functional Responses of Neutrophil Subsets in Severe COVID-19 Patients
McLeish, K. R., Shrestha, R., Vashishta, A., Rane, M. J., Barati, M. T., Brier, M. E., Lau, M. G., Hu, X., Chen, O., Wessel, C. R., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.879686 · Cited by 28
Insights into the tissue repair features of MAIT cells
Gao, M., & Zhao, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1432651 · Cited by 24
Chu, C.-F., Sabath, F., Fibi-Smetana, S., Sun, S., Öllinger, R., Noeßner, E., Chao, Y.-Y., Rinke, L., Winheim, E., Rad, R., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.601080 · Cited by 25
Differential dynamics of peripheral immune responses to acute SARS-CoV-2 infection in older adults
Lewis, S. A., Sureshchandra, S., Zulu, M. Z., Doratt, B. M., Jankeel, A., Ibraim, I. C., Pinski, A. N., Rhoades, N. S., Curtis, M., Jiang, X., et al. (2021) · Nature Aging · doi:10.1038/s43587-021-00127-2 · Cited by 23
Extensive Mendelian randomization study identifies potential causal risk factors for severe COVID-19
Sun, Y., Zhou, J., & Ye, K. (2021) · Communications Medicine · doi:10.1038/s43856-021-00061-9 · Cited by 28
Gur, I., Giladi, A., Isenberg, Y. N., Neuberger, A., & Stern, A. (2022) · Acta Haematologica · doi:10.1159/000523872 · Cited by 24
Khalid, Z., Ma, H., Raza, M. S., Abbas, M., Naz, Z., Kombe, A. J. K., Zeng, W., He, H., & Jin, T. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.901848 · Cited by 28
Islam, M. S., Wang, Z., Abdel‐Mohsen, M., Chen, X., & Montaner, L. J. (2023) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiac001 · Cited by 29
Genetic and environmental interactions contribute to immune variation in rewilded mice
Oyesola, O. O., Downie, A. E., Howard, N., Barre, R. S., Kiwanuka, K. N., Zaldana, K. S., Chen, Y.-H., Menezes, A., Lee, S. C., Devlin, J. C., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-01862-5 · Cited by 27
Blanco‐Rodríguez, R., Du, X., & Hernandez-Vargas, E. A. (2021) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2021.106412 · Cited by 23
Emerging Effects of IL-33 on COVID-19
Gao, Y., Cai, L., Li, L., Zhang, Y., Li, J., Luo, C., Wang, Y., & Tao, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113656 · Cited by 25
Nonsteroidal anti-inflammatory drugs and glucocorticoids in COVID-19
Ricciotti, E., Laudański, K., & FitzGerald, G. A. (2021) · Advances in Biological Regulation · doi:10.1016/j.jbior.2021.100818 · Cited by 22
The immune response as a double‐edged sword: The lesson learnt during the COVID ‐19 pandemic
Agrati, C., Carsetti, R., Bordoni, V., Sacchi, A., Quintarelli, C., Locatelli, F., Ippolito, G., & Capobianchi, M. R. (2022) · Immunology · doi:10.1111/imm.13564 · Cited by 24
Natural killer cells for antiviral therapy
Smith, D. M., Schafer, J. R., Tullius, B. P., Witkam, L., & Paust, S. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abl5278 · Cited by 22
Extensive acute and sustained changes to neutrophil proteomes post-SARS-CoV-2 infection
Long, M. B., Howden, A. J. M., Keir, H. R., Rollings, C. M., Giam, Y. H., Pembridge, T., Delgado, L., Abo-Leyah, H., Lloyd, A. F., Sollberger, G., et al. (2023) · European Respiratory Journal · doi:10.1183/13993003.00787-2023 · Cited by 24
Biomaterials-Based Opportunities to Engineer the Pulmonary Host Immune Response in COVID-19
Jarai, B. M., Stillman, Z. S., Bomb, K., Kloxin, A. M., & Fromen, C. A. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c01287 · Cited by 23
Rutkowska, E., Kwiecień, I., Kulik, K., Chełstowska, B., Kłos, K., Rzepecki, P., & Chciałowski, A. (2021) · Cells · doi:10.3390/cells10010082 · Cited by 23
Castanha, P. M. S., Tuttle, D. J., Kitsios, G. D., Jacobs, J. L., Braga-Neto, U., Duespohl, M., Rathod, S., Martí, M. M., Wheeler, S., Naqvi, A., et al. (2022) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac091 · Cited by 23
Kyei-Barffour, I., Akwetey, S. A., Aninagyei, E., Ghartey‐Kwansah, G., & Acheampong, D. O. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112282 · Cited by 21
García-González, P. A., Tempio, F., Fuentes, C., Merino, C., Vargas, L., Simon, V., Ramírez-Pereira, M., Rojas, V. A., Tobar, E. A., Landskron, G., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.769059 · Cited by 21
SARS-CoV-2 Accessory Protein ORF8 Decreases Antibody-Dependent Cellular Cytotoxicity
Beaudoin-Bussières, G., Arduini, A., Bourassa, C., Medjahed, H., Gendron‐Lepage, G., Richard, J., Pan, Q., Wang, Z., Liang, C., & Finzi, A. (2022) · Viruses · doi:10.3390/v14061237 · Cited by 22
The deciphering of the immune cells and marker signature in COVID‐19 pathogenesis: An update
Jasim, S. A., Mahdi, R. S., Bokov, D. O., Najm, M. A. A., Sobirova, G. N., Bafoeva, Z. O., Taifi, A., Alkadir, O. K. A., Mustafa, Y. F., Mirzaei, R., et al. (2022) · Journal of Medical Virology · doi:10.1002/jmv.28000 · Cited by 25
Neuraminidase is a host‐directed approach to regulate neutrophil responses in sepsis and COVID‐19
Formiga, R. D. O., AMARAL, F. C., de Souza, C. F., Mendes, D. A. G. B., Wanderley, C. W. S., Lorenzini, C. B., Santos, A. A., Antônia, J., Faria, L. F., Natale, C. C., et al. (2022) · British Journal of Pharmacology · doi:10.1111/bph.16013 · Cited by 23
SARS-CoV-2 infection and immune responses
Harne, R., Williams, B., Abdelaal, H. F. M., Baldwin, S. L., & Coler, R. N. (2023) · AIMS Microbiology · doi:10.3934/microbiol.2023015 · Cited by 24
Mesenchymal Stem Cells in the Treatment of COVID-19
Guo, B.-C., Wu, K., Chen, C., Lin, W.-Y., Chang, Y., Lee, T.-A., Lin, M.-J., & Wu, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914800 · Cited by 23
Schuurman, A. R., Reijnders, T. D. Y., Saris, A., Ramirez‐Moral, I., Schinkel, M., de Brabander, J., van Linge, C. C. A., Vermeulen, L., Scicluna, B. P., Wiersinga, W. J., et al. (2021) · eLife · doi:10.7554/elife.69661 · Cited by 23
SARS-CoV-2-Specific T Cell Responses in Patients with COVID-19 and Unexposed Individuals
Rha, M., Kim, A. R., & Shin, E. (2021) · Immune Network · doi:10.4110/in.2021.21.e2 · Cited by 26
Bohländer, F., Riehl, D., Weißmüller, S., Gutscher, M., Schüttrumpf, J., & Faust, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.700429 · Cited by 24
Sharapova, T. N., Romanova, E. A., Чернов, А. С., Minakov, A. N., Kazakov, V. A., Kudriaeva, A. A., Belogurov, A. A., Ivanova, O. K., Gabibov, A. G., Telegin, G. B., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011213 · Cited by 21
Immune response to COVID-19 in older adults
Jergović, M., Coplen, C. P., Uhrlaub, J. L., & Nikolich‐Žugich, J. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.04.017 · Cited by 21
Hussain, A., Rafeeq, H., Asif, H. M., Shabbir, S., Bilal, M., Mulla, S. I., Franco, M., & Iqbal, H. M. N. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108050 · Cited by 21
Prolonged enhancement of cytotoxic T lymphocytes in the post-recovery state of severe COVID-19
Mitsuyama, Y., Yamakawa, K., Kayano, K., Maruyama, M., Wada, T., & Fujimi, S. (2021) · Journal of Intensive Care · doi:10.1186/s40560-021-00591-3 · Cited by 20
Fouladseresht, H., Talepoor, A. G., Eskandari, N., Norouzian, M., Ghezelbash, B., Beyranvand, M. R., Nejadghaderi, S. A., Carson‐Chahhoud, K., Kolahi, A., & Safiri, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.785946 · Cited by 22
Habel, J. R., Chua, B. Y. L., Kedzierski, Ł., Selva, K. J., Damelang, T., Haycroft, E. R., Nguyen, T. H. O., Koay, H., Nicholson, S. R., McQuilten, H. A., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.167157 · Cited by 20
Potts, M., Fletcher-Etherington, A., Nightingale, K., Mescia, F., Bergamaschi, L., Calero‐Nieto, F. J., Antrobus, R., Williamson, J. C., Parsons, H. T., Huttlin, E. L., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112613 · Cited by 21
Utrero‐Rico, A., Ruiz‐Hornillos, J., González‐Cuadrado, C., Rita, C. G., Almoguera, B., Mínguez, P., Herrero, A., Fernández‐Ruiz, M., Carretero, O., Taracido‐Fernández, J. C., et al. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.02.021 · Cited by 20
An update on host immunity correlates and prospects of re-infection in COVID-19
Negi, N., Maurya, S. P., Singh, R., & Das, B. K. (2021) · International Reviews of Immunology · doi:10.1080/08830185.2021.2019727 · Cited by 23
Ali, E. T., Jabbar, A. S., Ali, H. S. A., Hamadi, S. S., Jabir, M. S., & Albukhaty, S. (2022) · International Journal of Inflammation · doi:10.1155/2022/5735546 · Cited by 26
Immune defects associated with lower SARS-CoV-2 BNT162b2 mRNA vaccine response in aged people
Vitallé, J., Pérez‐Gómez, A., Ostos, F. J., Gasca‐Capote, C., Jiménez‐León, M. R., Bachiller, S., Rivas‐Jeremías, I., Silva-Sánchez, M. D. M., Ruiz-Mateos, A. M., Martín-Sánchez, M. Á., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.161045 · Cited by 22
Immune response induced by novel coronavirus infection
Sun, Y., Zou, Y., Wang, H., Cui, G., Yu, Z., & Ren, Z. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.988604 · Cited by 21
Phenotypes and Functions of SARS-CoV-2-Reactive T Cells
Jung, M. K., & Shin, E. (2021) · Molecules and Cells · doi:10.14348/molcells.2021.0079 · Cited by 20
Byazrova, M. G., Kulemzin, S. V., Astakhova, E. A., Николаевна, Б. Т., Efimov, G. A., Chikaev, A. N., Kolotygin, I. O., Gorchakov, A. A., Taranin, A. V., & Filatov, A. V. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.840707 · Cited by 21
An efficient immunoassay for the B cell help function of SARS-CoV-2-specific memory CD4+ T cells
Ansari, A., Sachan, S., Jit, B. P., Sharma, A. K., Coshic, P., Sette, A., Weiskopf, D., & Gupta, N. (2022) · Cell Reports Methods · doi:10.1016/j.crmeth.2022.100224 · Cited by 21
Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits
Kim, S., Kim, J., Jang, J. Y., Noh, H., Park, J., Jeong, H., Jeon, D., Uhm, C., Oh, H., Cho, K., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1055811 · Cited by 23
Self-citationMarkov, N. S., Ren, Z., Senkow, K. J., Grant, R. A., Gao, C. A., Malsin, E. S., Sichizya, L., Kihshen, H., Helmin, K. A., Jovisic, M., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-01914-w · Cited by 19
Regulation of the human NK cell compartment by pathogens and vaccines
Goodier, M. R., & Riley, E. M. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1244 · Cited by 19
Complexity of immune responses in COVID-19
Mather, M. W., Jardine, L., Talks, B. J., Gardner, L. C. S., & Haniffa, M. A. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2021.101545 · Cited by 19
The nervous system during COVID ‐19: Caught in the crossfire
Natale, N. R., Lukens, J. R., & Petri, W. A. (2022) · Immunological Reviews · doi:10.1111/imr.13114 · Cited by 22
Aiello, A., Grossi, A., Meschi, S., Meledandri, M., Vanini, V., Petrone, L., Casetti, R., Cuzzi, G., Salmi, A., Altera, A. M. G., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.920227 · Cited by 18
Rutkowska, E., Kwiecień, I., Żabicka, M., Maliborski, A., Raniszewska, A., Kłos, K., Urbańska, W., Klajnowicz, I., Rzepecki, P., & Chciałowski, A. (2021) · Viruses · doi:10.3390/v13050880 · Cited by 19
On Deep Landscape Exploration of COVID-19 Patients Cells and Severity Markers
Vázquez-Jiménez, A., de León, U. A.-P., Matadamas-Guzman, M. L., Muciño-Olmos, E. A., Martínez-López, Y. E., Escobedo-Tapia, T., & Reséndis-Antonio, O. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.705646 · Cited by 19
Evaluating the Immune Response in Treatment-Naive Hospitalised Patients With Influenza and COVID-19
Legebeke, J., Lord, J., Penrice-Randal, R., Vallejo, A. F., Poole, S., Brendish, N. J., Dong, X., Hartley, C. S., Holloway, J. W., Lucas, J. S., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.853265 · Cited by 20
Astakhova, E. A., Byazrova, M. G., Yusubalieva, G. M., Kulemzin, S. V., Kruglova, N. A., Prilipov, A. G., Baklaushev, V. P., Gorchakov, A. A., Taranin, A. V., & Filatov, A. V. (2022) · Cells · doi:10.3390/cells11131991 · Cited by 19
Zulu, M. Z., Sureshchandra, S., Pinski, A. N., Doratt, B. M., Shen, W., & Messaoudi, I. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.760288 · Cited by 19
Multivariate indicators of disease severity in COVID-19
Bean, J., Kuri-Cervantes, L., Pennella, M., Betts, M. R., Meyer, N. J., & Hassan, W. M. (2023) · Scientific Reports · doi:10.1038/s41598-023-31683-9 · Cited by 18
Self-citationDobrynina, M. A., Ibragimov, R., Kritsky, I. S., Verkhovskaya, M. D., Mosunov, A. A., Петрович, С. Г., Zurochka, A. V., Александрович, З. В., Sarapultsev, A., Komelkova, M. V., et al. (2023) · Medical Immunology (Russia) · doi:10.15789/1563-0625-pci-2707 · Cited by 19
Kumar, A., Tripathi, P., Kumar, P., Shekhar, R., & Pathak, R. (2024) · Vaccines · doi:10.3390/vaccines12050459 · Cited by 18
Najm, A., Alunno, A., Mariette, X., Terrier, B., Marco, G. D., Emmel, J., Mason, L., McGonagle, D., & Machado, P. (2021) · RMD Open · doi:10.1136/rmdopen-2020-001549 · Cited by 18
Calming the inflammatory storm in severe COVID-19 infections: Role of biologics- A narrative review
Banji, D., Alqahtani, S. S., Banji, O. J. F., Machanchery, S., & Shoaib, A. (2021) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2021.01.005 · Cited by 18
The Many Faces of Innate Immunity in SARS-CoV-2 Infection
Hanan, N., Doud, R. L., Park, I.-W., Jones, H. P., & Mathew, S. O. (2021) · Vaccines · doi:10.3390/vaccines9060596 · Cited by 18
Innate lymphoid cells (ILC) in SARS-CoV-2 infection
Kumar, A., Cao, W., Endrias, K., Kuchipudi, S. V., Mittal, S. K., & Sambhara, S. R. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2021.101008 · Cited by 17
de Campos‐Mata, L., Vaquero, S. T., Tachó‐Piñot, R., Piñero, J., Grasset, E. K., Arrieta‐Aldea, I., Melero, N. R., Carolis, C., Horcajada, J. P., Cerutti, A., et al. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1339 · Cited by 20
Lim, J., Puan, K. J., Wang, L. W., Teng, K. W. W., Loh, C. Y., Tan, K. P., Carissimo, G., Chan, Y., Poh, C. M., Lee, C. Y., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.710217 · Cited by 21
Haslbauer, J. D., Zinner, C., Stalder, A. K., Schneeberger, J., Menter, T., Bassetti, S., Mertz, K. D., Went, P., Matter, M. S., & Tzankov, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.763098 · Cited by 19
Anti-COVID-19 potential of Azadirachta indica (Neem) leaf extract
Eze, M. O., Ejike, C. E. C. C., Ifeonu, P., Udeinya, I. J., Udenigwe, C. C., & Uzoegwu, P. N. (2022) · Scientific African · doi:10.1016/j.sciaf.2022.e01184 · Cited by 24
Panoskaltsis, N., McCarthy, N. E., Stagg, A. J., Mummery, C. J., Husni, M., Arebi, N., Greenstein, D., Price, C. L., Al-Hassi, H. O., Koutinas, M., et al. (2021) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-020-02725-2 · Cited by 16
Delmonte, O. M., Oguz, C., Dobbs, K., Myint‐Hpu, K., Palterer, B., Abers, M. S., Draper, D., Truong, M., Kaplan, I. M., Gittelman, R., et al. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.12.011 · Cited by 17
Hubrack, S., Al‐Nesf, M. A., Agrebi, N., Raynaud, C. M., Abukhattab, M., Thomas, M. M., Ibrahim, T., Taha, S., Dermime, S., Merhi, M., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-93536-7 · Cited by 16
Codd, A. S., Hanna, S. J., Compeer, E. B., Richter, F. C., Pring, E. J., Gea-Mallorquí, E., Borsa, M., Moon, O. R., Scourfield, D. O., Ahern, D., et al. (2021) · Oxford Open Immunology · doi:10.1093/oxfimm/iqab016 · Cited by 19
Occurrence of COVID-19 Symptoms During SARS-CoV-2 Infection Defines Waning of Humoral Immunity
Wu, J., Liang, B.-Y., Fang, Y., Wang, H., Yang, X., Shěn, S., Chen, L., Li, S., Lu, S., Xiang, T., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.722027 · Cited by 16
Aparicio, B., Casares, N., Egea, J., Ruiz, M., Llópiz, D., Maestro, S., Olagüe, C., González‐Aseguinolaza, G., Smerdou, C., de Cerio, A. L.-D., et al. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.1978823 · Cited by 17
The Transient IFN Response and the Delay of Adaptive Immunity Feature the Severity of COVID-19
Xu, G., Qi, F., Wang, H., Liu, Y., Wang, X., Zou, R., Yuan, J., Liao, X., Liu, Y., Zhang, S., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.816745 · Cited by 18
Capelle, C., Ciré, S., Domingues, O., Ernens, I., Hedin, F., Fischer, A., Snoeck, C. J., Ammerlaan, W., Konstantinou, M., Grzyb, K., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100600 · Cited by 18
Latifi-Pupovci, H. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113368 · Cited by 19
Massart, N., Reizine, F., Fillâtre, P., Séguin, P., Combe, B. L., Frerou, A., Egreteau, P.-Y., Hourmant, B., Kergoat, P., Lorber, J., et al. (2022) · Annals of Intensive Care · doi:10.1186/s13613-022-01057-x · Cited by 16
New Insights into SARS-CoV-2 and Cancer Cross-Talk: Does a Novel Oncogenesis Driver Emerge?
Rapti, V., Τσαγανός, Θ., Vathiotis, I. A., Syrigos, N. K., Li, P., & Poulakou, G. (2022) · Vaccines · doi:10.3390/vaccines10101607 · Cited by 16
Aspergillus-SARS-CoV-2 Coinfection: What Is Known?
Castro-Fuentes, C. A., Reyes-Montes, M. D. R., León, M. G. F.-D., Valencia-Ledezma, O. E., Acosta‐Altamirano, G., & Duarte-Escalante, E. (2022) · Pathogens · doi:10.3390/pathogens11111227 · Cited by 19
Liver-spleen axis dysfunction in COVID-19
Cococcia, S., Lenti, M. V., Santacroce, G., Achilli, G., de Andreis, F. B., & Sabatino, A. D. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i35.5919 · Cited by 17
Dannebaum, R., Suwalski, P., Asgharian, H., Du, Z. G., Lin, H., Weiner, J. M., Holtgrewe, M., Thibeault, C., Müller, M., Wang, X., et al. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101438 · Cited by 18
Nguyen, N.-A. A., Huang, X., Cabrera, L. E., Pekkarinen, P. T., Nowlan, K., Strandin, T. M., Kantele, A., Vapalahti, O., Heinonen, S., & Kekäläinen, E. (2022) · Cytometry Part A · doi:10.1002/cyto.a.24700 · Cited by 15
Immunohematologic Biomarkers in COVID-19: Insights into Pathogenesis, Prognosis, and Prevention
Sweet, D. R., Freeman, M. L., & Zidar, D. A. (2023) · Pathogens and Immunity · doi:10.20411/pai.v8i1.572 · Cited by 23
Karhadkar, T. R., Pilling, D., & Gomer, R. H. (2021) · PLoS ONE · doi:10.1371/journal.pone.0245924 · Cited by 15
Trunfio, M., Longo, B. M., Alladio, F., Venuti, F., Cerutti, F., Ghisetti, V., Bonora, S., Perri, G. D., & Calcagno, A. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.646679 · Cited by 15
Metadata
- Authors
- Kuri-Cervantes, L., Pampena, M. B., Meng, W., Rosenfeld, A. M., Ittner, C. A. G., Weisman, A. R., Agyekum, R. S., Mathew, D., Baxter, A. E., Vella, L. A., Kuthuru, O., Apostolidis, S. A., Bershaw, L., Dougherty, J., Greenplate, A. R., Pattekar, A., Kim, J., Han, N., Gouma, S., Weirick, M. E., Arevalo, C. P., Bolton, M. J., Goodwin, E. C., Anderson, E. M., Hensley, S. E., Jones, T. K., Mangalmurti, N. S., Luning Prak, E. T., Wherry, E. J., Meyer, N. J., & Betts, M. R.
- Affiliations
- University of Pennsylvania (US)
- Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
- Department of Pathology and Laboratory Medicine, Perelman School of Medicine, Philadelphia, PA 19104, USA.
- Children's Hospital of Philadelphia (US)
- Hospital of the University of Pennsylvania (US)
- Parker Institute for Cancer Immunotherapy (US)
- Corresponding author
- Kuri-Cervantes, Leticia
- Wherry, E. John
- Meyer, Nuala J.
- Betts, Michael R.
- ORCID
- Kuri-Cervantes, Leticia
- Pampena, Maria Betina
- Meng, Wenzhao
- Rosenfeld, Aaron M.
- Weisman, Ariel R.
- Agyekum, Roseline S.
- Mathew, Divij
- Baxter, Amy E.
- Vella, Laura A.
- Kuthuru, Oliva
- Apostolidis, Sokratis A.
- Bershaw, Luanne
- Dougherty, Jeanette
- Greenplate, Allison R.
- Pattekar, Ajinkya
- Kim, Justin
- Han, Nicholas
- Gouma, Sigrid
- Weirick, Madison E.
- Arevalo, Claudia P.
- Bolton, Marcus J.
- Anderson, Elizabeth M.
- Hensley, Scott E.
- Jones, Tiffanie K.
- Mangalmurti, Nilam S.
- Luning Prak, Eline T.
- Wherry, E. John
- Meyer, Nuala J.
- Betts, Michael R.
- Venue
- Science Immunology
- Published
- 2020-07-03
- Volume
- 5
- Issue
- 49
- ISSN
- 2470-9468 (ISSN-L)
- PMC
- PMC7402634
- OpenAlex
- W3042587425
- Cited by
- 723
- References
- 107
- Citations by year
- 2026: 15 · 2025: 27 · 2024: 63 · 2023: 101 · 2022: 182 · 2021: 251 · 2020: 83
- FWCI
- 20.38
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Science Immunology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (HL137006, HL137915, AI144288, P30-CA016520, AI105343, AI115712, AI117950, AI108545, AI082630, CA210944, T32 CA009140.)
- National Institute of Allergy and Infectious Diseases (AI136660)
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Keywords
- severe COVID-19, SARS-CoV-2, immune perturbation, hyperinflammation, T cell activation, innate lymphoid cells, granulocytes, neutrophil-to-lymphocyte ratio, prognostic factors, organ failure
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, Aged, Female, Humans, Immunity, Innate, Immunologic Memory, Lymphocyte Activation, Male, Middle Aged, Neutrophils, Pneumonia, Viral, T-Lymphocytes, B-Lymphocyte Subsets, Cytokines, Coronavirus Infections, Lymphocyte Count, Pandemics, Clonal Selection, Antigen-Mediated
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.